WebDisclosure WebDisclosure
Basculer en Français
11319 Companies
251546 Keywords
180680 Articles
137370 Press releases
Headlines Articles Press releases BIOMERIEUX Remove
  1. Home
  2. Companies
  3. BIOMERIEUX
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • REGULATED PRESS RELEASE

    published on 10/26/2023 at 07:01, 3 years ago

    bioMérieux – Information financière du 3ème trimestre 2023

    Logo of BIOMERIEUX
  • REGULATED PRESS RELEASE

    published on 10/19/2023 at 08:00, 3 years ago

    bioMérieux réalise un investissement stratégique dans Oxford Nanopore

    Logo of BIOMERIEUX
  • REGULATED PRESS RELEASE

    published on 10/19/2023 at 08:00, 3 years ago

    bioMérieux makes strategic investment in Oxford Nanopore

    Logo of BIOMERIEUX
  • REGULATED PRESS RELEASE

    published on 10/13/2023 at 07:02, 3 years ago

    bioMérieux announces CE-marking of VIDAS® TBI (GFAP, UCH-L1), a test for improved assessment of patients with mild traumatic brain injury, including concussion

    Logo of BIOMERIEUX
  • REGULATED PRESS RELEASE

    published on 10/13/2023 at 07:02, 3 years ago

    bioMérieux annonce le marquage CE du test VIDAS® TBI (GFAP, UCH-L1), pour une meilleure évaluation des patients victimes d’un traumatisme crânien léger, y compris pour les cas de commotion cérébrale

    Logo of BIOMERIEUX
  • REGULATED PRESS RELEASE

    published on 10/05/2023 at 14:15, 3 years 1 month ago

    Septembre 2023 - Déclaration sur le nombre d'actions composant le capital social et sur le nombre de droits de vote correspondant

    Logo of BIOMERIEUX
Previous page
1 ... 32 33
Accesswire
  • Published on 11/11/2026 at 16:30, 2 hours 20 minutes ago

    ShelfieTech Announces Expansion Agreement for Its Next-Generation AI Retail Intelligence Platform

  • Published on 11/11/2026 at 14:25, 4 hours 25 minutes ago

    Route1 Announces 2026 Annual Meeting Results

  • Published on 11/11/2026 at 14:00, 4 hours 50 minutes ago

    PPX Mining Reports Callanquitas Operating Results for the First Nine Months of 2026

  • Published on 11/11/2026 at 14:00, 4 hours 50 minutes ago

    NuRAN Wireless Board Approves Growth Strategy to Scale Recurring Revenue from 5,000+ Contracted Towers

  • Published on 11/11/2026 at 13:15, 5 hours 35 minutes ago

    Amarc Extends 2026 Exploration Program at the Duke District: Initiates Drilling Program at Established Porphyry Copper-Gold Targets

View all ACCESSWIRE
EQS Group
  • Published on 11/11/2026 at 18:41, 8 minutes ago

    AUSTRIACARD HOLDINGS AG: 9M 2026 Financial Results

  • Published on 11/11/2026 at 18:37, 13 minutes ago

    Holding(s) in Company

  • Published on 11/11/2026 at 18:36, 14 minutes ago

    Holding(s) in Company

  • Published on 11/11/2026 at 18:35, 15 minutes ago

    Holding(s) in Company

  • Published on 11/11/2026 at 18:33, 16 minutes ago

    Holding(s) in Company

View all EQS
Les Echos
  • Published on 11/10/2026 at 18:00, 1 day ago

    Déclaration du nombre total des droits de vote et du nombre d’actions au 31 octobre 2026

  • Published on 11/10/2026 at 17:45, 1 day 1 hour ago

    Damartex / Descriptif du programme de rachat d'actions

  • Published on 11/10/2026 at 17:40, 1 day 1 hour ago

    Production du 3ième trimestre 2026

  • Published on 11/10/2026 at 17:35, 1 day 1 hour ago

    ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 octobre 2026

  • Published on 11/10/2026 at 17:31, 1 day 1 hour ago

    CNP Assurances SA annonce le succès de l’émission d’une obligation subordonnée Tier 2 de 500 M€.

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy